Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
50%(2 trials)

Phase Distribution

Ph phase_3
1
20%
Ph phase_4
3
60%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)

Trials by Status

active_not_recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

NCT05542147
completedphase_4

Lowering Events in Non-proliferative Retinopathy in Scotland

NCT03439345
active_not_recruitingphase_4

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

NCT05498090
completedphase_4

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

NCT01927315
completedphase_3

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

NCT01674712

Clinical Trials (5)

Showing 5 of 5 trials
NCT05542147Not Applicable

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

Completed
NCT03439345Phase 4

Lowering Events in Non-proliferative Retinopathy in Scotland

Completed
NCT05498090Phase 4

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

Active Not Recruiting
NCT01927315Phase 4

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

Completed
NCT01674712Phase 3

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5